| John D Jeppson, MD | |
|
901 N Curtis Rd, Suite 100, Boise, ID 83706-1394 | |
| (208) 378-0080 | |
| (208) 378-0259 |
| Full Name | John D Jeppson |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 35 Years |
| Location | 901 N Curtis Rd, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417943622 | NPI | - | NPPES |
| 1215061734 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | M-6607 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Saint Alphonsus Regional Medical Center | Boise, ID | Hospital |
| Saint Alphonsus Medical Center - Ontario, Inc | Ontario, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boise Valley Asthma And Allergy Pa | 6901860014 | 7 |
News Archive
Maria Robles Garcia was sure her uncomfortable abdominal symptoms weren't caused by irritable bowel syndrome or from being overweight, no matter that her local doctors repeatedly told her that was the case.
Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.
GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.
CareFirst BlueCross BlueShield (CareFirst) today announced that it has joined with the American College of Physicians (ACP) to make available the ACP's Medical Home Builder- 2.0 (MHB 2.0) tool to participating CareFirst Patient-Centered Medical Home (PCMH) practices.
An editorial published by The BMJ today raises important concerns about the health and wellbeing of the NHS workforce after a parliamentary report found "burnout is a widespread reality in today's NHS."
› Verified 6 days ago
| Entity Name | Boise Valley Asthma & Allergy Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215061734 PECOS PAC ID: 6901860014 Enrollment ID: O20041118000313 |
News Archive
Maria Robles Garcia was sure her uncomfortable abdominal symptoms weren't caused by irritable bowel syndrome or from being overweight, no matter that her local doctors repeatedly told her that was the case.
Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.
GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.
CareFirst BlueCross BlueShield (CareFirst) today announced that it has joined with the American College of Physicians (ACP) to make available the ACP's Medical Home Builder- 2.0 (MHB 2.0) tool to participating CareFirst Patient-Centered Medical Home (PCMH) practices.
An editorial published by The BMJ today raises important concerns about the health and wellbeing of the NHS workforce after a parliamentary report found "burnout is a widespread reality in today's NHS."
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John D Jeppson, MD 901 N Curtis Rd, Suite 100, Boise, ID 83706-1394 Ph: (208) 378-0080 | John D Jeppson, MD 901 N Curtis Rd, Suite 100, Boise, ID 83706-1394 Ph: (208) 378-0080 |
News Archive
Maria Robles Garcia was sure her uncomfortable abdominal symptoms weren't caused by irritable bowel syndrome or from being overweight, no matter that her local doctors repeatedly told her that was the case.
Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.
GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.
CareFirst BlueCross BlueShield (CareFirst) today announced that it has joined with the American College of Physicians (ACP) to make available the ACP's Medical Home Builder- 2.0 (MHB 2.0) tool to participating CareFirst Patient-Centered Medical Home (PCMH) practices.
An editorial published by The BMJ today raises important concerns about the health and wellbeing of the NHS workforce after a parliamentary report found "burnout is a widespread reality in today's NHS."
› Verified 6 days ago
George William Palmer, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 901 N Curtis Rd, Ste 100, Boise, ID 83706 Phone: 208-378-0080 Fax: 208-378-0259 | |
Charles Nephi Webb, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Curtis Rd, Ste 303, Boise, ID 83706 Phone: 208-377-4000 Fax: 208-375-8426 | |
Michael V Keiley, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 901 N Curtis Rd, Ste 100, Boise, ID 83706 Phone: 208-378-0080 Fax: 208-378-0259 |